AstraZeneca: Revolutionizing Medicine Development and Manufacturing

AstraZeneca is using AI to revolutionize how it develops, makes, and supplies medicines. In drug development, predictive modeling helps optimize the physical and chemical properties of active pharmaceutical ingredients and predict the performance of formulated products during manufacturing, resulting in:

• A 50% reduction in development lead times.
• A 75% reduction in the use of active pharmaceutical ingredients in experiments.

In manufacturing, AI-powered process digital twins optimize the conditions for yield and productivity while reducing the use of raw materials and minimizing tech transfer requirements.